| # | Purification Step | HCP In (ng/mL) | HCP Out (ng/mL) | Step LRV | HCP ppm |
|---|---|---|---|---|---|
| Add purification steps to generate the report | |||||
HCP ppm (parts per million) is calculated as HCP (ng/mL) divided by product concentration (mg/mL), giving units of ng HCP per mg product (ng/mg). For example, if a drug substance contains 50 ng/mL HCP at a product concentration of 10 mg/mL, the HCP level is 50/10 = 5 ppm.
There is no universal regulatory limit, but widely accepted thresholds are less than 100 ppm for general parenteral products and less than 10 ppm for chronic or high-dose therapies. The EMA guideline on monoclonal antibodies (EMA/CHMP/BWP/532517/2008) expects manufacturers to demonstrate consistently low HCP levels and justify their acceptance criteria.
HCP Log Reduction Value for a single step is LRV = log10(HCP before / HCP after). If HCP drops from 100,000 ng/mL to 100 ng/mL across Protein A chromatography, the LRV is log10(100000/100) = 3.0, meaning 99.9% of host cell proteins were removed.
Protein A chromatography achieves 2.5 to 3.5 LRV because it is a highly specific affinity step. The Protein A ligand binds only the Fc region of antibodies while the vast majority of host cell proteins flow through unbound. This single step typically reduces HCP from 100,000-500,000 ng/mL to 500-5,000 ng/mL.
CHO harvests contain 100,000-500,000 ng/mL HCP, while E. coli lysates contain 1-5 million ng/mL because cell lysis releases the entire intracellular proteome. CHO mAb processes benefit from Protein A capture (2.5-3.5 LRV), making clearance straightforward. E. coli processes lack an equivalent high-selectivity step and typically require 5-7 cumulative LRV.
HCP per dose (ng) = HCP ppm (ng/mg) multiplied by the product dose (mg). For example, if the final drug substance has 5 ppm HCP and the dose is 100 mg, the patient receives 5 x 100 = 500 ng (0.5 micrograms) of HCP per administration.